According to the present paradigm 1,2 , naive T cells that express the chemokine receptor CCR7 and antigen-bearing mature CCR7 + dendritic cells (DCs) enter lymph nodes and migrate by a mechanism dependent on the chemokine CCL19 to the T cell zone, where antigenspecific encounters and T cell priming takes place. However, mice of the plt (paucity of lymph node T cells) strain 3 , which lack the CCR7 ligands CCL19 and CCL21a, can have normal or even enhanced CD4 + T cell responses 4,5 , which suggests that DC-dependent priming of some CD4 + T cell responses may occur outside the T cell zone in the lymph node. Indeed, emerging evidence suggests that T cells and DCs may also have the opportunity to engage each other near the B cell area. For example, follicular helper T cells (T FH cells) 6-8 and some DCs in the marginal zone of the spleen 9 and the dermis of the skin 10 express the chemokine receptor CXCR5 and localize near CXCR5 + B cells, stroma-derived follicular dendritic cells 11, 12 and marginal reticular cells 13 . Those stromal-cell subsets, which are located below the subcapsular sinus, in the B cell follicles and in the inter-and perifollicular regions between the B cell follicles, express the chemokine CXCL13 and can attract or retain CXCR5-expressing cells. Although it makes sense that the development of T FH cells, which is dependent on antigenpresenting DCs and B cells [14] [15] [16] , might take place near B cell follicles, it is less obvious whether other types of CD4 + effector-cell responses can be initiated in the B cell area of the lymph node.
A r t i c l e s
According to the present paradigm 1,2 , naive T cells that express the chemokine receptor CCR7 and antigen-bearing mature CCR7 + dendritic cells (DCs) enter lymph nodes and migrate by a mechanism dependent on the chemokine CCL19 to the T cell zone, where antigenspecific encounters and T cell priming takes place. However, mice of the plt (paucity of lymph node T cells) strain 3 , which lack the CCR7 ligands CCL19 and CCL21a, can have normal or even enhanced CD4 + T cell responses 4, 5 , which suggests that DC-dependent priming of some CD4 + T cell responses may occur outside the T cell zone in the lymph node. Indeed, emerging evidence suggests that T cells and DCs may also have the opportunity to engage each other near the B cell area. For example, follicular helper T cells (T FH cells) [6] [7] [8] and some DCs in the marginal zone of the spleen 9 and the dermis of the skin 10 express the chemokine receptor CXCR5 and localize near CXCR5 + B cells, stroma-derived follicular dendritic cells 11, 12 and marginal reticular cells 13 . Those stromal-cell subsets, which are located below the subcapsular sinus, in the B cell follicles and in the inter-and perifollicular regions between the B cell follicles, express the chemokine CXCL13 and can attract or retain CXCR5-expressing cells. Although it makes sense that the development of T FH cells, which is dependent on antigenpresenting DCs and B cells [14] [15] [16] , might take place near B cell follicles, it is less obvious whether other types of CD4 + effector-cell responses can be initiated in the B cell area of the lymph node.
Here we found that a population of CXCR5-expressing DCs that migrated to the lymph node and localized adjacent to B cell follicles was induced in mice infected with the intestinal nematode Heligmosomoides polygyrus. Deletion of CXCR5 in either DCs or CD4 + T cells prevented the colocalization of DCs and CD4 + T cells near the B cell area and impaired the development of both T FH cell and type 2 helper T cell (T H 2 cell) effectors. Notably, lymphotoxinexpressing B cells controlled Cxcl13 transcription and regulated the CXCL13-dependent positioning of DCs and T cells in the lymph node. Most notably, cytokine production by T H 2 effector cells in the lymph nodes and peripheral tissues was substantially impaired in mice treated with therapeutics that either caused transient depletion of B cells or blocked signaling via membrane lymphotoxin or CXCL13. Thus, H. polygyrus-induced, IL-4-expressing T FH and T H 2 effector-cell responses were initiated in a CXCL13-, lymphotoxin-and B cell-dependent way in a specialized microenvironment outside the T cell zone.
RESULTS

H. polygyrus infection alters DC chemokine-receptor expression
Mature DCs typically localize in the T cell zone of the lymph node 17, 18 . However, CXCR5 + DC populations have been identified and found to localize near B cell follicles 9, 10 . To assess whether we were able to detect DCs that 'preferentially' localized near B cells after various types of infections, we determined the localization of the DCs in the mediastinal lymph nodes (medLNs) of influenza virus-infected C57BL/6J (B6) mice or the mesenteric lymph nodes (mesLNs) of H. polygyrus-infected mice. As expected, CD11c + DCs were present mainly in the T cell areas of uninfected mice (Fig. 1a) . Similarly, medLN CD11c + DCs from influenza virus-infected mice were also present mainly in the T cell area (Fig. 1a) . In contrast, mesLN CD11c + DCs from H. polygyrus-infected mice were located below the subcapsular sinus, in the interfollicular areas and at the T cell-B cell border (Fig. 1) . Thus, DCs accumulated in different regions of the lymph node after infection with influenza virus or H. polygyrus.
Given the unexpected positioning of the CD11c + cells in the mesLNs of H. polygyrus-infected mice, we phenotypically and functionally characterized the CD11c + DCs in the lymph nodes on day 8, at the peak of the DC response ( Supplementary Fig. 1a ). We identified two main populations of DCs: MHCII + CD40 hi CD11c int DEC-205 + mature DCs and MHCII lo CD40 lo CD11c hi DEC-205 − immature DCs (Fig. 2a,b) . As expected, we found eight-to tenfold more mature mesLN DCs after H. polygyrus infection (Supplementary Fig. 1a) . Notably, we identified similar migratory DC subsets in the medLNs of influenza virus-infected mice 19 ( Supplementary Fig. 1b-i) .
As the MHCII + CD11c int CD40 hi DEC-205 + DCs in the medLNs of influenza virus-infected mice present influenza virus antigens 19 npg of culture, we measured the in vitro population expansion of the IL-4 mRNA-expressing T cell population that is 'reported' in these mice by expression of enhanced green fluorescent protein (eGFP). Approximately 10% of the input CD4 + T cells expressed eGFP before culture with DCs (Fig. 2c, far left) . The eGFP + T cell population expanded tenfold when cultured together with mature DCs from H. polygyrus-infected mice (Fig. 2c,d ), which suggested that these phenotypically mature DCs were able to present H. polygyrus antigen and expand H. polygyrus-specific CD4 + T cell populations. Next we assessed the expression of CCR7 and CXCR5 on immature (MHCII lo CD11c hi CD40 lo ) DCs and mature (MHCII + CD11c int CD40 hi ) DCs from the mesLNs and medLNs of uninfected, influenza virusinfected or H. polygyrus-infected mice. As expected, most immature DCs were CCR7 − CXCR5 − (Fig. 2e) . However, ~80% of mature DCs from the medLNs and mesLNs of uninfected mice and from the medLNs of influenza virus-infected mice expressed CCR7 (Fig. 2f-h ). In contrast, only 25-30% of mature DCs from the mesLNs of H. polygyrus-infected mice had detectable expression of CCR7 (Fig. 2g,h) . Instead, most of those DCs expressed CXCR5 (Fig. 2g,h) , alone or in combination with CCR7 (Supplementary Fig. 2a) .
To determine whether mature DCs from H. polygyrus-infected mice were altered in their ability to respond to ligands of CCR7 and CXCR5, we did in vitro chemotaxis assays. Immature DCs did not migrate toward CCL19 or CXCL13 (Fig. 2i) , whereas mature lymph node DCs from uninfected or influenza virus-infected mice responded to CCL19 but responded only marginally to CXCL13 (Fig. 2j) . Conversely, mature DCs from H. polygyrus-infected mice showed more migration toward CXCL13 and less migration toward CCL19 (Fig. 2j) . In fact, the frequency of mature DCs that migrated toward CCL19 decreased from 22% before infection to 8% after infection with H. polygyrus, whereas the frequency of DCs that migrated toward CXCL13 more than doubled, from 3% to 8% ( Supplementary  Fig. 2b ). Not unexpectedly, given the higher CXCR5 expression in B cells than in mature DCs (Supplementary Fig. 2c) , B cells from H. polygyrus-infected mesLNs migrated more effectively to CXCL13 than did mature DCs from the same lymph nodes ( Supplementary  Fig. 2d,e) . However, antigen-bearing migratory mesLN DCs from H. polygyrus-infected mice showed altered responsiveness to chemokines such as CXCL13 and CCL19 that control the positioning of cells in the lymph node. T H 2 responses to H. polygyrus regulated by CXCL13 but not CCL19 Given the altered responsiveness of mature DCs from H. polygyrusinfected mice to CCL19 and CXCL13, we postulated that the development of T H 2 responses to H. polygyrus might be less reliant on CCR7 ligands and more dependent on CXCR5 ligands. To test our hypothesis, we first evaluated T cell responses in H. polygyrus-infected CCL19-deficient plt mice. As expected 3 , the mesLNs of naive plt mice had fewer mature Fig. 3a,b) . However, by 8 d after infection with H. polygyrus, B6 and plt mice had a similar frequency and number of immature and mature mesLN DCs (Fig. 3a,b) . Furthermore, DCs of each group of mice were present below the subcapsular sinus and in the interfollicular areas (Fig. 3c) . More notably, both the frequency and number of CD4 + T cells from H. polygyrus-infected mice that produced IL-4 after restimulation in vitro with antibody to CD3 (anti-CD3) were almost identical for plt and B6 mice (Fig. 3d,e) , which indicated that CCL19 was not required for the H. polygyrus-dependent development of T H 2 cells.
Next we treated mice with control antibody or CXCL13-specific antibody at the time of H. polygyrus infection and examined the DC and T cell responses 8 d later. Blockade of CXCL13 had no effect on lymph node cellularity or the number of immature and mature DCs in the reactive lymph node (Fig. 3f) . However, DCs from mice treated with anti-CXCL13 localized in the T cell area rather than near the B cell follicles (Fig. 3g) . Despite the presence of the DCs in the T cell zone of infected mice treated with anti-CXCL13, the frequency and number of mesLN CD4 + T cells that produced IL-4 after restimulation with anti-CD3 were significantly lower for mice treated with anti-CXCL13 than for mice treated with control antibody (Fig. 3h,i) . We obtained similar results with H. polygyrusinfected Cxcl13 −/− mice 21 and Cxcr5 −/− mice 22 (Fig. 3h,i) . Notably, the frequency and number of IL-4 producing T H 2 cells present in a peripheral site, the peritoneal cavity, were also significantly lower for mice treated with anti-CXCL13 than for mice treated with control antibody (Fig. 3j,k) . In contrast, treatment with anti-CXCL13 did not impair the development of interferon-γ (IFN-γ)-producing type 1 helper T cells (T H 1 cells) after infection with influenza virus (Fig. 3l,m) . Therefore, although CXCL13 was important for the development of an H. polygyrus-specific T H 2 response in the lymph nodes and periphery, it was dispensable for the development of a T H 1 response to influenza virus.
CXCR5 + DCs regulate H. polygyrus-induced T H 2 development
To determine whether the T H 2 responses to H. polygyrus were dependent on CXCR5-expressing DCs, we reconstituted irradiated wild-type B6 recipients with an 80:20 mixture of bone marrow from CD11c-DTR mice, in which DCs can be ablated after the administration of diphtheria toxin 23 , and Cxcr5 −/− mice, respectively (to generate DC-Cxcr5 −/− chimeras; Supplementary Fig. 4) , or with an 80:20 mixture of bone marrow from CD11c-DTR mice and wild-type B6 mice, respectively (to generate DC-WT chimeras; Supplementary  Fig. 4 ). After reconstitution, we treated both groups with diphtheria toxin to ablate the CD11c + cells derived from the CD11c-DTR bone marrow. We then transferred purified naive CD4 + T cells from congenic B6 (CD45.1 + ) mice into chimeras of each group and infected the mice with H. polygyrus. Although the frequency (Fig. 4a) and number (data not shown) of mesLN DCs were similar for both groups of mice, most responding DCs present in the diphtheria toxin-treated H. polygyrus-infected DC-WT chimeras expressed CXCR5, whereas the responding DCs from DC-Cxcr5 −/− chimeras were largely CXCR5 − (Fig. 4b) . DCs from H. polygyrus-infected DC-WT chimeras were positioned in the interfollicular regions (Fig. 4c) , whereas DCs from H. polygyrus-infected DC-Cxcr5 −/− chimeras accumulated mostly in the T cell zone (Fig. 4c) . Notably, the DC-Cxcr5 −/− chimeras had a significantly lower frequency and number of IL-4-producing wildtype (CD45.1 + ) CD4 + T cells in the mesLNs (Fig. 4d,e) and peritoneal cavity (Fig. 4f,g ) than did DC-WT chimeras. Thus, CXCR5 expression by CD11c + cells controlled the positioning of DCs in the infected lymph nodes and was also necessary for the development of maximal T H 2 responses in lymph nodes and peripheral sites.
T FH and T H 2 development requires CXCR5 + T cells
Our data suggested that H. polygyrus-induced T H 2 responses might also be dependent on a CXCR5-expressing T cell population. To address this possibility, we used flow cytometry to assess CXCR5 expression on (Fig. 5a) . As expected, PD-1 lo T H 2 cells produced both IL-4 ( Fig. 5b) and IL-13 ( Supplementary  Fig. 5a ) after restimulation with anti-CD3 and were present in peripheral sites such as the peritoneal cavity (Supplementary Fig. 5b ). In contrast, after infection with H. polygyrus, we did not detect the PD-1 hi T FH population in the peritoneal cavity of B6 mice ( Supplementary  Fig. 5b ) or in the lymph nodes of 4getµMT mice, which are genetically deficient in B cells but have the gene encoding the IL-4 reporter (Supplementary Fig. 5c ). None of the PD-1 hi T FH cells restimulated with anti-CD3 produced IL-13 ( Supplementary Fig. 5a ), and only a small fraction made IL-4 (Fig. 5b) . However, as expected, PD-1 hi T FH cells had abundant expression of CXCR5 and intracellular expression of the transcriptional repressor Bcl-6 (Fig. 5c,d and Supplementary  Fig. 5d) . Unexpectedly, the eGFP + PD-1 lo T H 2 cells in the mesLNs also expressed CXCR5 and Bcl-6, albeit in smaller amounts than observed in the T FH cells (Fig. 5c,d and Supplementary Fig. 5d ).
As both T FH cells and T H 2 cells in H. polygyrus-infected mesLNs expressed CXCR5, we expected to find that these cells localized in a CXCL13-dependent way near B cell follicles. Using anti-CD8 to define the T cell zone and anti-B220 to define B cell follicles, we first examined the positioning of CD4 + T cells and CD11c + DCs in H. polygyrusinfected mesLNs. Some CD4 + T cells localized together with CD8 + T cells in the T cell zone. However, unlike CD8 + T cells, CD4 + T cells were also present in the perifollicular area and B cell follicles (Fig. 5e) . 
A r t i c l e s
After treatment with anti-CXCL13, CD4 + T cells no longer accumulated in the perifollicular region and instead accumulated in the T cell area (Fig. 5f) . Despite the finding that treatment with anti-CXCL13 facilitated the colocalization of CD4 + T cells and DCs in the T cell zone, there were significantly fewer ICOS + PD-1 hi T FH cells (Fig. 5g) and IL-4-producing ICOS + PD-1 lo T H 2 cells (Fig. 5h) after treatment with anti-CXCL13 than after treatment with control antibody. To address whether CXCR5-expressing T cells were necessary for the H. polygyrus-induced development of T H 2 and T FH cells, we reconstituted irradiated wild-type B6 (CD45.1 + ) recipient mice with a 50:50 mixture of wild-type B6 (CD45.1 + ) bone marrow and Cxcr5 −/− (CD45.2 + ) bone marrow (Supplementary Fig. 6 ). We infected the reconstituted chimeric mice with H. polygyrus and determined the frequency of B6 (CD45.1 + ) and Cxcr5 −/− (CD45.2 + ) cells in the mesLNs and peritoneal cavity on day 8 after infection. The chimeras had an equivalent frequency of total B6 and Cxcr5 −/− mesLN cells (Fig. 5i) , and the frequency of naive CD44 lo CD4 + T cells of each genotype was identical (Fig. 5j) . However, the frequency of Cxcr5 −/− ICOS + PD-1 hi T FH cells and Cxcr5 −/− ICOS + PD-1 lo effector cells was significantly lower than the equivalent populations of wild-type B6 cells (Fig. 5j) . Notably, the frequency of IL-4-producing Cxcr5 −/− CD4 + T cells in the mesLNs (Fig. 5k) and peritoneal cavity (Fig. 5l) was also much lower than the frequency of IL-4-producing wild-type B6 T cells in these tissues. Therefore, the optimal development of lymph node T FH responses and of lymph node and peripheral T H 2 responses to H. polygyrus was dependent on a CXCR5-expressing T cell population.
B cell depletion impairs T FH and T H 2 development
Given that CXCR5 expression by both CD4 + T cells and DCs was required for maximal T FH and T H 2 responses to H. polygyrus, we reasoned that localization of B cells together with DCs or CD4 + T cells may be necessary for the optimal generation of T H 2 cells. To assess this, we treated wild-type B6 mice with control antibody or B cell-depleting anti-CD20 4 d before infecting the mice with H. polygyrus and, on day 8 after infection, we evaluated the architecture of the mesLNs and the CD4 + T cell response. In mice treated with control antibody, DCs and CD4 + T cells were positioned in close proximity to B cells ( Fig. 6a and Supplementary Fig. 7 ). In contrast, in mice treated with anti-CD20, B cell follicles were ablated (Fig. 6b) and DCs and CD4 + T cells were disorganized and present throughout the lymph node (Fig. 6a,b and Supplementary Fig. 7 ). As expected, mice depleted of B cells had significantly fewer ICOS + PD-1 hi T FH cells than did mice treated with control antibody (Fig. 6c) . However, mice depleted of B cells had a significantly lower frequency and number of ICOS + PD-1 lo IL-4 + T H 2 cells (Fig. 6d,e) and IL-13-producing T H 2 cells (Supplementary Fig. 8a,b) in the lymph nodes (Fig. 6d,e) and IL-4 + CD4 + T cells in the peritoneal cavity (Supplementary Fig. 8c,d ) than did mice treated with control antibody. We obtained similar results with H. polygyrus-infected MD4µMT mice, which have a monoclonal repertoire of B cells that express a transgene encoding a B cell antigen receptor specific for an irrelevant antigen ( Supplementary Fig. 8e-g) . As a control, we also depleted mice of B cells, treated them with anti-CD20 and infected them with influenza virus, then determined the number of influenza virus nucleoprotein-specific ICOS + PD-1 hi T FH cells and ICOS + PD-1 lo effector T cells in the medLNs on day 8. Although depleting mice of B cells suppressed the nucleoprotein-specific T FH cell response (Fig. 6f) , it had no effect on the nucleoprotein-specific IFN-γ-producing CD4 + T H 1 response at day 8 after infection (Fig. 6g,h) . Thus, B cells and CXCL13 were dispensable for the development of a primary T H 1 response to influenza virus but were necessary for the generation of an optimal T H 2 response to H. polygyrus.
Lymphotoxin regulates CXCL13 expression and T H 2 development CXCL13 expression by stromal cells in the spleen is controlled by lymphotoxin-expressing B cells 24 . To investigate whether lymphotoxin-expressing B cells regulate the CXCR5-dependent T H 2 response by controlling CXCL13 expression in the mesLNs, we first examined membrane expression of lymphotoxin-α 1 β 2 on mesLN cells after infection with H. polygyrus. Although mesLN T cells had only marginal expression of lymphotoxin (Supplementary Fig. 9a ), we detected lymphotoxin on a fraction of mesLNs B cells from uninfected mice (Fig. 7a) and found it was upregulated on B cells after infection with H. polygyrus (Fig. 7b) , specifically in the activated (Fas + PNA lo ) and germinal-center (PNA hi Fas + ) B cell populations (Supplementary Fig. 9b) . npg Notably, neither nonspecific B cells from MD4µMT mice (Fig. 7c) nor B cells from CD11c-DTR mice depleted of DCs (Fig. 7d ) upregulated lymphotoxin after infection with H. polygyrus. We next determined whether CXCL13 expression in the lymph nodes of H. polygyrus-infected mice was controlled by lymphotoxin or B cells. To assess this, we either depleted mice of B cells with anti-CD20 or blocked lymphotoxin signaling with a fusion protein consisting of the receptor for lymphotoxin-β and the Fc portion of immunoglobulin (LTβR-Fc). We then infected the mice with H. polygyrus and quantified CXCL13 mRNA in the mesLNs. We found significantly lower CXCL13 expression in the mesLNs of mice depleted of B cells or treated with LTβR-Fc than in infected B6 mice treated with control antibody (data not shown) or control protein (Fig. 7e) , respectively.
Finally, we treated mice with LTβR-Fc at the time of infection with H. polygyrus and then examined the positioning of DCs and CD4 + T cells in the lymph nodes and the development of the H. polygyrusinduced T H 2 response. Neither the frequency nor the number of mature DCs was affected by treatment with LTβR-Fc (Fig. 7f,g ). Although treatment with LTβR-Fc did not ablate the B cell follicles (Fig. 7h,i) , DCs and CD4 + T cells in the mice treated with LTβR-Fc no longer accumulated in the interfollicular areas and were instead present mostly in the T cell areas of the lymph nodes (Fig. 7h,i and Supplementary  Fig. 10) . Furthermore, mice treated with LTβR-Fc and infected with H. polygyrus had significantly fewer IL-4-producing T cells than did infected B6 mice treated with protein (Fig. 7j) . Thus, CXCL13, B cells and lymphotoxin were each required for the proper positioning of DCs and T cells near the B cell follicles after infection with H. polygyrus and were also required for the optimal development of T H 2 cells.
B cell-derived lymphotoxin controls T H 2 responses to H. polygyrus
Collectively, our data suggested that lymphotoxin produced by B cells regulated CXCL13 expression and thereby controlled the positioning of DCs and T cells in the mesLNs and the development of an H. polygyrus-specific T H 2 response. To assess that model, we reconstituted µMT mice (which are genetically deficient in B cells) with bone marrow containing 80% µMT bone marrow plus 20% B6 bone marrow or 20% Lta −/− bone marrow. In these chimeras, the B cells were either lymphotoxin deficient 25 (B-Lta −/− ) or lymphotoxin sufficient (B-WT; Supplementary Fig. 11 ). We infected both groups of chimeric mice with H. polygyrus and evaluated the DC response, CXCL13 expression and T H 2 response in the mesLNs on day 8 after infection. The numbers of mature and immature DCs in the mesLNs of H. polygyrusinfected B-Lta −/− chimeras were equivalent to those in the mesLNs of infected B-WT chimeras (Fig. 8a,b) . Although DCs from H. polygyrusinfected B-WT chimeras were adjacent to the B cell follicles (Fig. 8c) , DCs from infected B-Lta −/− chimeras accumulated mainly in the T cell area with the CD4 + T cells (Fig. 8d) . Consistent with those results, CXCL13 mRNA expression was lower in H. polygyrus-infected B-Lta −/− chimeras than in infected B-WT chimeras (Fig. 8e) . Furthermore, the frequency and number of CD4 + T cells able to produce IL-4 after restimulation were significantly lower in the infected B-Lta −/− chimeras than in B-WT chimeras (Fig. 8f,g ). Together these data indicated that 
DISCUSSION
Although present models suggest that naive T cells are first primed by antigen-bearing DCs in the T cell zone 17, 26, 27 , we have shown here that optimal development of H. polygyrus-induced T FH and T H 2 cells required CXCR5, CXCL13 and lymphotoxin and seemed to take place outside the T cell zone, adjacent to B cell follicles. We found that treatment with anti-CXCL13 and LTβR-Fc, which impaired the development of T H 2 cells in response to H. polygyrus, did not prevent the colocalization of CD4 + T cells and DCs in the T cell zone but did prevent those cells from accumulating near the B cell follicles. Thus, T H 2 responses to H. polygyrus were not only dependent on DC-T cell interactions but also controlled by the microenvironment in which these interactions occurred.
Our data indicated that expression of CXCR5 by DCs was required for optimal T FH and T H 2 responses to H. polygyrus. Although activated DCs typically upregulate CCR7 (ref. 18 ), we found very few CCR7 + CXCR5 − DCs after infection with H. polygyrus. Instead, we identified populations of CXCR5 + CCR7 − and CXCR5 + CCR7 + mature DCs. Some of these DCs were responsive, at least in vitro, to CCL19 and CXCL13. Although these H. polygyrus-induced DCs were less responsive to CXCL13 than were B cells, the DCs were also less responsive to CCL19 than were the 'prototypical' mature DCs from influenza virus-infected mice. This dual, but modest, responsiveness to ligands of CCR7 and CXCR5 seemed sufficient for the migratory DCs to reach the lymph node. However, once the DCs entered the subcapsular sinus region of the lymph node through the lymphatics, the DCs would encounter CXCL13. We speculate that CXCL13 probably provided a retention signal and prevented the DCs, which were only modestly responsive to CCL19, from migrating to the T cell area. CXCR5-expressing DCs have been identified in the marginal zone of the spleen and the dermis of the skin 9, 10 . Although the function of these DCs was not evaluated, the CXCR5 + skin-derived DCs responded to CXCL13 and migrated to the B cell area of the lymph node after adoptive transfer 10 . Furthermore, the marginal-zone CXCR5 + DCs disappeared in mice lacking B cells or lymphotoxin 9 . Thus, these splenic and skin-derived populations of DCs may be similar to the CXCR5-expressing DC population induced after infection with H. polygyrus.
CXCR5 expression by T cells was also required for optimal T FH and T H 2 responses to H. polygyrus. Although T FH cells express CXCR5 (refs. 6-8), a role for CXCR5 in T H 2 development has not been evaluated. We found a population of CXCR5-and Bcl-6-expressing mesLN T cells that also had the phenotypic and functional hallmarks of true T H 2 cells 28 that are committed to the production of IL-4 and IL-13. Given that both T FH cells and T H 2 cells in the mesLNs of H. polygyrus-infected mice expressed IL-4 mRNA and Bcl-6 and required B cells and CXCL13 for their optimal development, it seems that the H. polygyrus-induced differentiation of T FH cells and T H 2 cells is linked. In support of that conclusion, T FH and T H 2 cells responding to Schistosoma mansoni egg antigens are reported to arise from a common precursor 29 . Similarly, it has been reported that T H 1 differentiation is marked by a T FH cell-like transition 30 . Our data further indicate that the development of this common T FH -T H 2 precursor is controlled in part by the unique microenvironment in which the cells are located. We speculate that naive H. polygyrusspecific T cells that enter the lymph node near B cell follicles are detained at this site by CXCR5 + antigen-presenting DCs and are directed to activate the transcription networks that control both T FH differentiation 7, 8 and T H 2 differentiation 28 . T cells that receive reinforcing signals from nearby antigen-presenting B cells can maintain expression of Bcl-6 and CXCR5 and become fully committed T FH cells [14] [15] [16] that retain their ability to produce 31) . In contrast, those T cells that do not maintain extended interactions with antigen-presenting B cells lose Bcl-6 and CXCR5 expression [14] [15] [16] T FH responses [14] [15] [16] , regulate the magnitude of primary T H 2 responses [32] [33] [34] [35] and facilitate the development and maintenance of memory T H 2 cells 32, 34 . Our data have shown that one way B cells modulate the development of T FH and T H 2 effector cells is by ensuring abundant expression of CXCL13 in the B cell area of the reactive lymph node, thereby enhancing the retention of CXCR5 + DCs and CD4 + T cells in this location. Given our data showing that B cells controlled the abundance of CXCL13 in a lymphotoxin-dependent way in the lymph node, we speculate that lymphotoxin-expressing B cells communicate with nearby LTβR-expressing stromal cells 24, [36] [37] [38] and induce those cells to produce more CXCL13, which allows more effective retention of CXCR5-expressing DCs. This infection-induced response in the lymph node seems similar to the homeostatic feedback loop by which lymphotoxin-expressing B cells organize the T cell area and CXCL13-expressing follicular dendritic cells in the spleen 21, 39 . It is not immediately obvious why T FH -and T H 2-dependent responses to H. polygyrus were more effective when T cells and DCs localized together in the perifollicular area than when they localized together in in the T cell zone. One possibility is that B cells that present antigen and express cytokines or costimulatory molecules may be needed to drive the differentiation of T H 2 and T FH cells. Alternatively, other cells, such as macrophages that line the subcapsular sinus and transfer antigens to B cells, also populate the perifollicular area 40, 41 and may contribute to the process. It is also possible that IL-4-producing cells such as mast cells 28 Collectively, our results support a model of DC-driven CD4 + T cell differentiation in which pathogen-derived signals instruct DCs to upregulate CXCR5, migrate to a unique microenvironment in the lymph node and initiate the development of T FH and T H 2 cells. Although we do not know whether this model is applicable to all T H 2 responses, we have found that T H 2 responses in Leishmania major-infected BALB/c mice were controlled in a similar CXCR5-and CXCL13-dependent way (B.L. and F.E.L., data not shown). Finally, and perhaps most notably, our data suggest that some T H 2 responses may be attenuated with therapeutics that result in the depletion of B cells or block CXCL13 or lymphotoxin signaling.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
